Paradigm Capital Management Boosted Its Rti Surgical (RTIX) Stake; Brandywine Global Investment Management Has Raised Bristol Myers Squibb Co (BMY) Position By $52.30 Million

May 20, 2018 - By Michael Collier

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Brandywine Global Investment Management Llc increased Bristol Myers Squibb Co (BMY) stake by 387.53% reported in 2017Q4 SEC filing. Brandywine Global Investment Management Llc acquired 857,411 shares as Bristol Myers Squibb Co (BMY)’s stock rose 2.38%. The Brandywine Global Investment Management Llc holds 1.08 million shares with $66.10M value, up from 221,250 last quarter. Bristol Myers Squibb Co now has $86.18B valuation. The stock decreased 0.06% or $0.03 during the last trading session, reaching $52.71. About 6.44M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since May 20, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Paradigm Capital Management Inc increased Rti Surgical Inc (RTIX) stake by 2.26% reported in 2017Q4 SEC filing. Paradigm Capital Management Inc acquired 131,052 shares as Rti Surgical Inc (RTIX)’s stock rose 9.64%. The Paradigm Capital Management Inc holds 5.93 million shares with $24.31M value, up from 5.80 million last quarter. Rti Surgical Inc now has $294.94 million valuation. The stock increased 2.20% or $0.1 during the last trading session, reaching $4.65. About 105,510 shares traded. RTI Surgical, Inc. (NASDAQ:RTIX) has risen 21.33% since May 20, 2017 and is uptrending. It has outperformed by 9.78% the S&P500.

Among 2 analysts covering RTI Surgical (NASDAQ:RTIX), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. RTI Surgical had 2 analyst reports since October 30, 2015 according to SRatingsIntel. On Friday, March 2 the stock rating was upgraded by Craig Hallum to “Buy”. As per Friday, October 30, the company rating was downgraded by Canaccord Genuity.

Paradigm Capital Management Inc decreased Amer Eagle Outfitters (NYSE:AEO) stake by 24,150 shares to 212,150 valued at $3.99M in 2017Q4. It also reduced Kelly Services Inc Class A (NASDAQ:KELYA) stake by 18,625 shares and now owns 61,200 shares. Ichor Holdings was reduced too.

More news for RTI Surgical, Inc. (NASDAQ:RTIX) were recently published by: Seekingalpha.com, which released: “RTI Surgical’s (RTIX) CEO Camille Farhat on Q1 2018 Results – Earnings Call Transcript” on May 05, 2018. Streetinsider.com‘s article titled: “RTI Surgical (RTIX) Reports In-Line Q1 EPS, Beats on Revenues; Affirms FY18 Guidance” and published on May 03, 2018 is yet another important article.

Investors sentiment increased to 1.35 in Q4 2017. Its up 0.24, from 1.11 in 2017Q3. It increased, as 9 investors sold RTIX shares while 28 reduced holdings. 20 funds opened positions while 30 raised stakes. 42.10 million shares or 1.07% more from 41.65 million shares in 2017Q3 were reported. Art Advisors Limited Liability Com holds 0% in RTI Surgical, Inc. (NASDAQ:RTIX) or 11,763 shares. 1.11 million are owned by Foundry. Clarivest Asset Mgmt Ltd Limited Liability Company has invested 0% in RTI Surgical, Inc. (NASDAQ:RTIX). Jane Street Group Ltd Limited Liability Company has invested 0% in RTI Surgical, Inc. (NASDAQ:RTIX). Price T Rowe Assoc Incorporated Md has invested 0% in RTI Surgical, Inc. (NASDAQ:RTIX). Macquarie Gru Limited holds 0% or 109,184 shares in its portfolio. 774,490 are held by Kennedy Cap Mgmt. Teton Advsr Incorporated stated it has 66,000 shares. Tower Rech Capital Ltd Co (Trc) reported 0.01% of its portfolio in RTI Surgical, Inc. (NASDAQ:RTIX). Jacobs Levy Equity Mgmt Inc reported 246,366 shares. Blackrock has 4.91 million shares for 0% of their portfolio. Ameriprise Financial Inc owns 67,987 shares for 0% of their portfolio. Millennium Management Ltd Liability has 591,647 shares for 0% of their portfolio. Legal And General Group Incorporated Pcl invested 0% of its portfolio in RTI Surgical, Inc. (NASDAQ:RTIX). Landscape Cap Mgmt Limited Liability Corporation accumulated 36,147 shares.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Bizjournals.com which released: “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” on May 01, 2018, also Seekingalpha.com with their article: “Jounce down 32% premarket on announcement of trial data on lead candidate JTX-2011” published on May 17, 2018, Fool.com published: “Why Bristol-Myers Squibb Stock Crashed in April” on May 09, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Benzinga.com and their article: “BMO Sees Balanced Risk-Reward In Bristol-Myers, Takes Neutral Position” published on April 27, 2018 as well as Streetinsider.com‘s news article titled: “Morgan Finds Positive Datapoints For MRK and BMY At ASCO” with publication date: May 17, 2018.

Brandywine Global Investment Management Llc decreased Sucampo Pharmaceuticals Inc (NASDAQ:SCMP) stake by 18,393 shares to 78,107 valued at $1.40 million in 2017Q4. It also reduced Wabtec Corp (NYSE:WAB) stake by 31,323 shares and now owns 24,700 shares. Employers Holdings Inc (NYSE:EIG) was reduced too.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 2 Sell and 13 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 86 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Wednesday, October 18 by Citigroup. The stock has “Hold” rating by SunTrust on Monday, October 16. Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, September 15 with “Buy” rating. The stock has “Buy” rating by Jefferies on Monday, December 19. Robert W. Baird initiated the shares of BMY in report on Wednesday, April 26 with “Outperform” rating. The rating was maintained by Barclays Capital on Tuesday, December 1 with “Equal Weight”. As per Friday, August 5, the company rating was downgraded by Morgan Stanley. Jefferies maintained the shares of BMY in report on Monday, February 26 with “Hold” rating. The rating was downgraded by Berenberg on Thursday, August 11 to “Hold”. Jefferies maintained the shares of BMY in report on Wednesday, August 23 with “Buy” rating.

Since December 12, 2017, it had 2 insider purchases, and 1 insider sale for $163,963 activity. 4,000 shares were bought by Samuels Theodore R. II, worth $249,187. 4,770 shares were bought by Paliwal Dinesh C, worth $249,948 on Monday, April 30. Lynch Thomas J. Jr. sold $335,172 worth of stock or 5,300 shares.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.09, from 1.03 in 2017Q3. It worsened, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Cap Fund Management reported 186,980 shares or 0.06% of all its holdings. Diversified Trust Com, a Tennessee-based fund reported 7,792 shares. Private Tru Commerce Na owns 61,997 shares. Stonebridge Cap Advisors Ltd reported 1.12% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Spinnaker Tru invested 0.29% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Fukoku Mutual Life Ins has 0.94% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 101,890 shares. Toronto Dominion Commercial Bank has invested 0.13% in Bristol-Myers Squibb Company (NYSE:BMY). State Treasurer State Of Michigan reported 0.36% in Bristol-Myers Squibb Company (NYSE:BMY). Gofen And Glossberg Limited Liability Il has invested 0.1% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Eagle Glob Limited Liability holds 0.01% or 4,465 shares. Tennessee-based Patten And Patten Tn has invested 1.08% in Bristol-Myers Squibb Company (NYSE:BMY). Macnealy Hoover Invest Mngmt stated it has 16,194 shares or 0.72% of all its holdings. Sol Cap Mgmt has invested 0.34% in Bristol-Myers Squibb Company (NYSE:BMY). Cranbrook Wealth Ltd Llc owns 1,654 shares. Moreover, Altfest L J And Inc has 1.41% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 60,800 shares.

RTI Surgical, Inc. (NASDAQ:RTIX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: